Press Releases
Endo USA, Inc. Issues Voluntary, Nationwide Recall of One Lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Lot Number 550147301 Due to Mislabeling: Incorrect Strength on Product Carton
Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC®
Endo Files Registration Statement with SEC, Advancing Planned Move to NYSE
Endo Announces Commencement of OTCQX Trading
Endo Launches New Dupuytren's Contracture Campaign: Reminders
Endo Provides Select First-Quarter 2024 Financial Results for Endo International plc
Endo to Announce First-Quarter 2024 Financial Results for Endo International plc
Endo Announces New Peyronie's Disease Data Presented at the American Urological Association Annual Meeting
Endo Launches Enhanced TruDelivery® Ready-to-Use Product Line and Platform
Endo, Inc. Completes Acquisition of Endo International plc's Assets